Cargando…

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants

Long-acting drug delivery is a growing area of interest as it overcomes many challenges related to patient adherence to therapy and the pill burden associated with chronic illness. Injectable formulations are becoming more common and drug-releasing implants also provide several opportunities. Highly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shakil, Anika, Hern, Faye Y., Liu, Chung, Temburnikar, Kartik, Chambon, Pierre, Liptrott, Neill, McDonald, Tom O., Neary, Megan, Owen, Andrew, Freel Meyers, Caren, Rannard, Steve P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199480/ https://www.ncbi.nlm.nih.gov/pubmed/35604111 http://dx.doi.org/10.1039/d2tb00825d

Ejemplares similares

Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
por: Curley, Paul, et al.
Publicado: (2023)

Recent advances in synthetic approaches for medicinal chemistry of C-nucleosides
por: Temburnikar, Kartik, et al.
Publicado: (2018)

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
por: Hobson, James J., et al.
Publicado: (2019)

The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors
por: Fernandes, Lívia da Rocha, et al.
Publicado: (2023)

Prodrugs of γ‐Alkyl‐Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase
por: Zhao, Chenglong, et al.
Publicado: (2020)

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019)

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
por: Pradere, Ugo, et al.
Publicado: (2014)

Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018)

Quantification of branching within high molecular weight polymers with polyester backbones formed by transfer-dominated branching radical telomerisation (TBRT)
por: Cassin, Savannah R., et al.
Publicado: (2021)

Designing single trigger/dual-response release and degradation into amine-functional hyperbranched-polydendron nanoprecipitates
por: Rogers, Hannah E., et al.
Publicado: (2020)

Nucleoside diphosphate and triphosphate prodrugs – An unsolvable task?
por: Meier, Chris
Publicado: (2017)

Vitamin E Phosphate Nucleoside Prodrugs: A Platform for Intracellular Delivery of Monophosphorylated Nucleosides
por: Daifuku, Richard, et al.
Publicado: (2018)

Preclinical and clinical development of the anti-HIV, anti-HBV oxathiolane nucleoside analog emtricitabine
por: Painter, George R., et al.
Publicado: (2003)

The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2
por: Feng, Joy Y., et al.
Publicado: (2022)

Synthesis and Evaluation of Prodrugs of α-Carboxy Nucleoside Phosphonates
por: Ford, Alan, et al.
Publicado: (2022)

Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
por: Liptrott, Neill J., et al.
Publicado: (2018)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Controlling the pH-response of branched copolymer nanoprecipitates synthesised by transfer-dominated branching radical telomerisation (TBRT) through telogen chemistry and spatial distribution of tertiary amine functionality
por: Penrhyn-Lowe, Oliver B., et al.
Publicado: (2022)

Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals
por: Gollnest, Tristan, et al.
Publicado: (2015)

Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF
por: Mills, Anthony, et al.
Publicado: (2015)

Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
por: Sinokrot, Hanadi, et al.
Publicado: (2017)

Development of triazine non-nucleoside reverse transcriptase inhibitors for microbicidal applications
por: Ariën, Kevin K, et al.
Publicado: (2011)

Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
por: Marfatia, Yogesh S., et al.
Publicado: (2014)

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2016)

Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
por: Vanangamudi, Murugesan, et al.
Publicado: (2023)

Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?
por: Tatham, Lee M., et al.
Publicado: (2019)

Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
por: Wu, Pei-Ying, et al.
Publicado: (2017)

NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
por: Thammaporn, Ratsupa, et al.
Publicado: (2015)

Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides
por: McGuigan, Christopher, et al.
Publicado: (2013)

Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs
por: Pileggi, Elisa, et al.
Publicado: (2018)

Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies
por: Xu, Xingxing, et al.
Publicado: (2023)

Revealing Donor Substrate-Dependent Mechanistic Control on DXPS, an Enzyme in Bacterial Central Metabolism
por: Johnston, Melanie L., et al.
Publicado: (2021)

DXP Synthase Function in a Bacterial Metabolic Adaptation and Implications for Antibacterial Strategies
por: Chen, Eric C., et al.
Publicado: (2023)

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review
por: Rutherford, George W., et al.
Publicado: (2016)

Anhydrous nanoprecipitation for the preparation of nanodispersions of tenofovir disoproxil fumarate in oils as candidate long-acting injectable depot formulations
por: Hobson, James J., et al.
Publicado: (2019)

The structure of FIV reverse transcriptase and its implications for non-nucleoside inhibitor resistance
por: Galilee, Meytal, et al.
Publicado: (2018)

Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors—In Silico Activity Prediction
por: Dąbrowska, Aleksandra, et al.
Publicado: (2018)

Nucleoside Analog Reverse-Transcriptase Inhibitors in Membrane Environment: Molecular Dynamics Simulations
por: Stachowicz-Kuśnierz, Anna, et al.
Publicado: (2023)

Mucus-responsive functionalized emulsions: design, synthesis and study of novel branched polymers as functional emulsifiers
por: Edwards, Stephanie E., et al.
Publicado: (2020)

The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
por: Tsume, Yasuhiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q16cfcnus5gtfn9timfdv8fdq5